BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34269527)

  • 1. An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response.
    Knepper TC; Panchaud RA; Muradova E; Cohen L; DeCaprio JA; Khushalani NI; Tsai KY; Brohl AS
    Cancer Med; 2021 Sep; 10(17):5889-5896. PubMed ID: 34269527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.
    Knepper TC; Montesion M; Russell JS; Sokol ES; Frampton GM; Miller VA; Albacker LA; McLeod HL; Eroglu Z; Khushalani NI; Sondak VK; Messina JL; Schell MJ; DeCaprio JA; Tsai KY; Brohl AS
    Clin Cancer Res; 2019 Oct; 25(19):5961-5971. PubMed ID: 31399473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merkel Cell Carcinoma Therapeutic Update.
    Cassler NM; Merrill D; Bichakjian CK; Brownell I
    Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics.
    Cohen PR; Tomson BN; Elkin SK; Marchlik E; Carter JL; Kurzrock R
    Oncotarget; 2016 Apr; 7(17):23454-67. PubMed ID: 26981779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropomyosin Receptor Kinase A Expression on Merkel Cell Carcinoma Cells.
    Wehkamp U; Stern S; Krüger S; Hauschild A; Röcken C; Egberts F
    JAMA Dermatol; 2017 Nov; 153(11):1166-1169. PubMed ID: 28793172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
    D'Angelo SP; Bhatia S; Brohl AS; Hamid O; Mehnert JM; Terheyden P; Shih KC; Brownell I; Lebbé C; Lewis KD; Linette GP; Milella M; Georges S; Shah P; Ellers-Lenz B; Bajars M; Güzel G; Nghiem PT
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
    Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
    BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
    Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma.
    Spassova I; Ugurel S; Kubat L; Zimmer L; Terheyden P; Mohr A; Björn Andtback H; Villabona L; Leiter U; Eigentler T; Loquai C; Hassel JC; Gambichler T; Haferkamp S; Mohr P; Pfoehler C; Heinzerling L; Gutzmer R; Utikal JS; Horny K; Schildhaus HU; Habermann D; Hoffmann D; Schadendorf D; Becker JC
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35074902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Merkel Cell Carcinoma.
    Harms PW
    Clin Lab Med; 2017 Sep; 37(3):485-501. PubMed ID: 28802497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of PI3K signaling in Merkel cell carcinoma.
    Nardi V; Song Y; Santamaria-Barria JA; Cosper AK; Lam Q; Faber AC; Boland GM; Yeap BY; Bergethon K; Scialabba VL; Tsao H; Settleman J; Ryan DP; Borger DR; Bhan AK; Hoang MP; Iafrate AJ; Cusack JC; Engelman JA; Dias-Santagata D
    Clin Cancer Res; 2012 Mar; 18(5):1227-36. PubMed ID: 22261808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival.
    Vandeven N; Lewis CW; Makarov V; Riaz N; Paulson KG; Hippe D; Bestick A; Doumani R; Marx T; Takagishi S; Chan TA; Choi J; Nghiem P
    Clin Cancer Res; 2018 Feb; 24(4):963-971. PubMed ID: 29246939
    [No Abstract]   [Full Text] [Related]  

  • 13. UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
    Wong SQ; Waldeck K; Vergara IA; Schröder J; Madore J; Wilmott JS; Colebatch AJ; De Paoli-Iseppi R; Li J; Lupat R; Semple T; Arnau GM; Fellowes A; Leonard JH; Hruby G; Mann GJ; Thompson JF; Cullinane C; Johnston M; Shackleton M; Sandhu S; Bowtell DD; Johnstone RW; Fox SB; McArthur GA; Papenfuss AT; Scolyer RA; Gill AJ; Hicks RJ; Tothill RW
    Cancer Res; 2015 Dec; 75(24):5228-34. PubMed ID: 26627015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Merkel cell polyomavirus positivity with PDGFRα mutations and survivin expression in Merkel cell carcinoma.
    Batinica M; Akgül B; Silling S; Mauch C; Zigrino P
    J Dermatol Sci; 2015 Jul; 79(1):43-9. PubMed ID: 25936870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.
    Donepudi S; DeConti RC; Samlowski WE
    Semin Oncol; 2012 Apr; 39(2):163-72. PubMed ID: 22484188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Insights and Advances in the Management of Merkel Cell Carcinoma.
    Banks PD; Sandhu S; Gyorki DE; Johnston ML; Rischin D
    J Oncol Pract; 2016 Jul; 12(7):637-46. PubMed ID: 27407160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent update on tumour biology and treatment of Merkel Cell carcinoma].
    Steinstraesser L; Kueckelhaus M; Koljonen V
    Handchir Mikrochir Plast Chir; 2011 Dec; 43(6):345-9. PubMed ID: 22241518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hotspot mutations in polyomavirus positive and negative Merkel cell carcinomas.
    Veija T; Sarhadi VK; Koljonen V; Bohling T; Knuutila S
    Cancer Genet; 2016; 209(1-2):30-5. PubMed ID: 26725423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merkel cell carcinoma - recent advances in the biology, diagnostics and treatment.
    Czapiewski P; Biernat W
    Int J Biochem Cell Biol; 2014 Aug; 53():536-46. PubMed ID: 24811434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma.
    Brazel D; Kumar P; Doan H; Pan T; Shen W; Gao L; Moyers JT
    JAMA Netw Open; 2023 Jan; 6(1):e2249674. PubMed ID: 36602798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.